Built for the people who actually do this work.

RoseRx pre-screens the material against MA Code Edition 20 in minutes, identifying the specific clauses at risk before the committee meets.

RoseRx runs pre-screens across the full pipeline — attach your materials and results render as interactive, sortable compliance tables with status badges and citation markers you can click to verify. When revised materials come back from clients, RoseRx tracks which prior issues are resolved and which persist — so you manage every revision cycle with confidence.

RoseRx automatically fetches your cited references from PubMed, verifies every claim-reference pair, and flags unsupported or misrepresented citations with clause references. When revisions come back, RoseRx checks that prior issues have been addressed — no manual tracking needed.

RoseRx pre-screens every claim against the MA Code and cross-checks cited references before the client's internal review — catching misaligned claims, unsupported statistics, and missing fair balance before they become costly rejections.

RoseRx lets you query the Product Information directly, surfacing approved indications, contraindications, and precautions in plain language — so you write compliant copy from the start, not after three rounds of redlines.

RoseRx lets you rapidly interrogate multiple Product Information documents, extracting key indications, safety profiles, and competitive positioning — giving your strategy team clinical fluency in hours, not weeks.

RoseRx applies the latest MA Code edition to your materials automatically. When Edition 20 dropped, agencies using RoseRx identified affected materials within days — not months of manual re-review.

KOL Explorer and Engagement Analyst turn a manual KOL mapping engagement into a 30-minute query — with scored HCP profiles, competitive intelligence, and engagement timelines ready to present.

Your compliance dashboard shows every material's review round (Round 1, 2, 3…), issue resolution rate, and overall compliance score — so you can see at a glance which campaigns are on track and which need attention.

Engagement Analyst runs head-to-head competitive analysis between any two Medicines Australia member companies — showing shared KOLs, exclusive relationships, and engagement strategy gaps.

Reference Checker reads the clinical study report's efficacy charts visually. It verifies whether the promotional claim matches the data in the figure — and flags if the material uses relative risk reduction when the chart shows absolute risk.

Always-on safety vigilance detects, triages, and classifies adverse events and product complaints automatically — across every agent interaction, before you leave the car park. No separate tool to open, no extra step to remember.

Call Scribe transcribes the meeting in real time. Call Logger pushes accurate, structured call notes directly to your CRM — automatically.

Call Coach gives every rep structured AI feedback after every call — open and close technique, probing questions, Code-compliant claims, objective achievement. Every call becomes a coachable moment.

Engagement Analyst runs head-to-head competitive analysis between any two Medicines Australia member companies — showing shared KOLs, exclusive relationships, and engagement strategy gaps.

MI Analyst generates comprehensive, audit-ready standard response documents with full clinical context and TGA reporting compliance.

Every MI query is logged with product context and topic classification. Your dashboard surfaces query trends by product, therapeutic area, and question type — turning reactive responses into proactive medical strategy.

RoseRx deploys a conversational AI that guides patients through program eligibility, enrolment steps, and co-pay support in real time; triaging complex cases to your nurse team so they focus on patients who genuinely need human support.